In a report published Wednesday, Citigroup analyst Alvin C. Concepcion initiated coverage on CVS Health Corp CVS with a Neutral rating and $99.00 price target.
In the report, Citigroup noted, “We rate CVS Neutral with a $99 target price. While we believe the company is on track to achieve the top end of its long-term growth guidance and should benefit from its multi-channel business model, strong growth initiatives that are driving share gains, and industry tailwinds, we think much of this growth is reflected in the current stock price.”
CVS Health closed on Tuesday at $91.25.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in